Skip to content
Review Open access

Spatially organized macrophage–T-cell crosstalk in cervical cancer: insights from single-cell and spatial omics

Jul 2026 · Frontiers in Immunology · Vol 17 · 0 citations · 71 references
Medicine

TL;DR

Emerging high-dimensional atlases are synthesized to reframe macrophage–T-cell crosstalk from simple ligand–receptor interactions into a spatially organized ecological model to provide actionable translational insights for targeting macrophage vulnerabilities, guiding biomarker-driven combinatorial immunotherapies, and overcoming immune resistance in cervical cancer.

Abstract

Immunotherapy has transformed the therapeutic landscape of advanced cervical cancer, yet clinical benefit remains limited by a highly heterogeneous and immunosuppressive tumor microenvironment. Traditional paradigms, including binary M1/M2 macrophage polarization and models that interpret T-cell dysfunction solely through checkpoint expression, are insufficient to capture the localized intercellular dynamics that drive immune evasion. Recent advances in single-cell and spatial multi-omics have fundamentally reshaped our understanding of this landscape. In this review, we synthesize emerging high-dimensional atlases to reframe macrophage–T-cell crosstalk from simple ligand–receptor interactions into a spatially organized ecological model. We highlight the paradigm shift toward highly resolved myeloid programs, particularly SPP1+ and C1QC+ macrophage states, and discuss how these programs interact with stromal barriers, regulatory T cells, and metabolic checkpoints to restrict, exclude, or functionally constrain effector T cells within suppressive niches. Crucially, we position persistent high-risk human papillomavirus infection not merely as an initiating carcinogenic trigger, but as an upstream and continuous programmer that rewires innate immune sensing, including context-dependent cGAS–STING-related circuits, to stabilize local immune tolerance throughout disease progression. Finally, we propose translational strategies for distilling complex multi-omic atlases into pathology-compatible prognostic and predictive biomarker signatures. Ultimately, by deciphering these spatially organized networks, this review aims to provide actionable translational insights for targeting macrophage vulnerabilities, guiding biomarker-driven combinatorial immunotherapies, and overcoming immune resistance in cervical cancer.

Read PDF

Similar papers

Review Open access Sep 2026

Spatial and Temporal Heterogeneity of Macrophage Efferocytosis in Tumors: Emerging Implications for Immunotherapy Biomarkers and Therapeutic Timing

Resistance to immune checkpoint blockade (ICB) remains a major barrier in cancer therapy, reflecting the fact that tumor immunity is governed not only by cell type abundance but also by spatial organization and temporal dynamics within the tumor microenvironment (TME). In this review, we examine macrophage efferocytosi...

Shan-Yi Li, Ji-Lei Li, Zhen-Yu Zhang et al. · 0 citations
Review Open access Aug 2026

Spatially organized regulated cell death-immune coupling in solid tumors: integrating spatial omics with actionable regulated cell death biology

The therapeutic efficacy of immune checkpoint blockade is frequently compromised by the profound spatial heterogeneity of solid tumors, where distinct ecological niches are associated with different patterns of immune engagement. Spatial omics has substantially refined our understanding of tumor immune topographies. Th...

Jinkang Tong, Dian-Jie Zeng, Leyi Chen et al. · 0 citations
Open access Aug 2026

POSTN⁺ CAF–SPP1⁺ macrophage crosstalk is associated with immune exclusion and poor prognosis in lung adenocarcinoma

Lung adenocarcinoma (LUAD) is a highly lethal malignancy in which the tumor microenvironment (TME) plays an important role in disease progression and therapeutic resistance. However, the spatial organization and molecular basis of stromal–immune interactions in LUAD remain incompletely understood. We integrated bulk RN...

Ankang Zhu, Jian-Yuan Huang, Juan Zhang et al. · 0 citations
Review Open access Aug 2026

Spatial immune niches in gastric cancer immunotherapy resistance: mechanisms and translational implications

Immune checkpoint inhibitors have changed the treatment landscape for gastric and gastroesophageal junction adenocarcinoma, yet durable benefit remains uneven across biomarker-defined groups. PD-L1 combined positive score, MSI/dMMR, tumor mutational burden, EBV status, HER2, and CLDN18.2 guide treatment eligibility, bu...

Zi-Qiang Ling, Renzhe Tang, B. Yuan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.